Cargando…

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital

Detalles Bibliográficos
Autores principales:	Highgate, J, Escott, G, Lowe, A, Stedman, F, McNeillis, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472880/ http://dx.doi.org/10.1186/cc14382

Ejemplares similares

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

A pharmacokinetic basis for improving therapeutic outcomes of aminoglycoside therapy during continuous venovenous haemodiafiltration
por: Spooner, A, et al.
Publicado: (2007)

Valproic acid overdose and continuous venovenous haemodiafiltration
por: Jacobs, Frédéric M., et al.
Publicado: (2008)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Continuous venovenous haemofiltration in neonates
por: Mayell, S, et al.
Publicado: (2004)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

The efficacy of haemoperfusion combined with continuous venovenous haemodiafiltration in the treatment of severe viral encephalitis in children
por: Zhao, Jun-Lin, et al.
Publicado: (2023)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Early venovenous haemodiafiltration for sepsis-related multiple organ failure
por: Jacobs, Frédéric M, et al.
Publicado: (2006)

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit
por: Claisse, Guillaume, et al.
Publicado: (2015)

Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF)
por: Kirwan, Marcus, et al.
Publicado: (2021)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Effects of two different regional citrate anticoagulation CVVH protocols on acid-base status and phosphate supplementation
por: Morabito, S, et al.
Publicado: (2013)

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
por: D’Arcy, Deirdre M, et al.
Publicado: (2012)

Antibiotic dosing regimens for septic patients receiving continuous venovenous haemofiltration: do current studies supply sufficient data?
por: Li, A, et al.
Publicado: (2009)

Efficacy of continuous haemodiafiltration using a polymethylmethacrylate membrane haemofilter in the treatment of sepsis and acute respiratory distress syndrome
por: Sakai, M
Publicado: (2012)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fm9dvp685lishus5cgng7nfptu